C07K 14/4723
Cationic antimicrobial peptides
Official title: {Cationic antimicrobial peptides, e.g. defensins}
C07K14/4723 (Cationic antimicrobial peptides) appears on 384 US grants and 545 published applications in this corpus.
Search patents in C07K- Granted patents
- 384
- Published applications
- 545
- Assignees
- 300
- Inventors
- 920
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 12 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 1 |
| 2002 | 5 | 9 |
| 2003 | 7 | 13 |
| 2004 | 9 | 18 |
| 2005 | 5 | 19 |
| 2006 | 10 | 20 |
| 2007 | 8 | 18 |
| 2008 | 13 | 18 |
| 2009 | 11 | 31 |
| 2010 | 22 | 20 |
| 2011 | 19 | 31 |
| 2012 | 12 | 15 |
| 2013 | 15 | 22 |
| 2014 | 12 | 48 |
| 2015 | 32 | 24 |
| 2016 | 21 | 19 |
| 2017 | 12 | 25 |
| 2018 | 15 | 21 |
| 2019 | 18 | 23 |
| 2020 | 13 | 27 |
| 2021 | 13 | 28 |
| 2022 | 15 | 19 |
| 2023 | 6 | 22 |
| 2024 | 12 | 26 |
| 2025 | 10 | 11 |
| 2026 | 8 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biosensor comprising a plurality of functionalized sets of carbon atoms in the sp2 hybridisation state, preparation method thereof and use thereof, in particular for the detection of ecotoxicological risks25 Aug 2026US 12,716,083 B2Commissariat A L' Energie Atomique Et Aux Energies Alternatives
- Click outer membrane vesicles16 Jun 2026US 12,653,882 B2Intravacc B.V.
- Compositions including antimicrobial polymer-peptide conjugates and uses thereof9 Jun 2026US 12,648,571 B2University of Puerto Rico
- Antibody-payload conjugates with enhanced delivery domain and uses thereof2 Jun 2026US 12,643,944 B2Iprogen Biotech Inc.
- Engineered lysin-human defensin protein19 May 2026US 12,630,596 B2University of South Florida
- Antimicrobial defensin peptide folding variants1 Oct 2026US 2026/0297145 A1Donald Danforth Plant Science Center
- Antimicrobial nodule-specific cysteine-rich peptide folding variants1 Oct 2026US 2026/0297146 A1Donald Danforth Plant Science Center
- Compositions and Methods for Treatment of Protease Mediated Disease24 Sep 2026US 2026/0284144 A1The Regents of the University of California
- Antimicrobial peptides with alpha-core helices24 Sep 2026US 2026/0285927 A1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Nanostructured proteins and uses thereof10 Sep 2026US 2026/0265317 A1
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Engineered nucleic acids and methods of use thereof184US 9,464,124 B2Moderna Therapeutics, Inc. · 2016
- Defensin peptide compositions and methods for their use124US 5,242,902 AThe Regents of the University of California · 1993